Pablo J Cagnoni - Net Worth and Insider Trading
Pablo J Cagnoni Net Worth
The estimated net worth of Pablo J Cagnoni is at least $3,767 dollars as of 2024-12-27. Pablo J Cagnoni is the Director of Rubius Therapeutics Inc and owns about 66,082 shares of Rubius Therapeutics Inc (RUBY) stock worth over $3,767. Pablo J Cagnoni is also the Director of CRISPR Therapeutics AG and owns about 0 shares of CRISPR Therapeutics AG (CRSP) stock worth over $0. Details can be seen in Pablo J Cagnoni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pablo J Cagnoni has not made any transactions after 2023-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pablo J Cagnoni
Pablo J Cagnoni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pablo J Cagnoni owns 6 companies in total, including Turmeric Acquisition Corp (TMPMU) , Fusion Pharmaceuticals Inc (FUSN) , and Rubius Therapeutics Inc (RUBY) among others .
Click here to see the complete history of Pablo J Cagnoni’s form 4 insider trades.
Insider Ownership Summary of Pablo J Cagnoni
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TMPMU | Turmeric Acquisition Corp | 2020-10-15 | director |
FUSN | Fusion Pharmaceuticals Inc | 2020-06-25 | director |
RUBY | Rubius Therapeutics Inc | 2023-02-01 | director & Chief Executive Officer |
2019-11-19 | director | ||
2020-10-15 | director | ||
2023-06-07 | President & R&D |
Pablo J Cagnoni Latest Holdings Summary
Pablo J Cagnoni currently owns a total of 2 stocks. Among these stocks, Pablo J Cagnoni owns 66,082 shares of Rubius Therapeutics Inc (RUBY) as of February 1, 2023, with a value of $3,767 and a weighting of 100%. Pablo J Cagnoni also owns 0 shares of CRISPR Therapeutics AG (CRSP) as of November 19, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Pablo J Cagnoni
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RUBY | Rubius Therapeutics Inc | 2023-02-01 | 66,082 | 0.06 | 3,767 |
CRSP | CRISPR Therapeutics AG | 2019-11-19 | 0 | 41.07 | 0 |
Holding Weightings of Pablo J Cagnoni
Pablo J Cagnoni Form 4 Trading Tracker
According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 4 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 8,448 shares on February 1, 2023, which brought Pablo J Cagnoni around $2,112.
According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 7,500 shares on November 19, 2019, which brought Pablo J Cagnoni around $465,000.
Insider Trading History of Pablo J Cagnoni
- 1
Pablo J Cagnoni Trading Performance
GuruFocus tracks the stock performance after each of Pablo J Cagnoni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pablo J Cagnoni is 30.14%. GuruFocus also compares Pablo J Cagnoni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pablo J Cagnoni within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pablo J Cagnoni's insider trading performs compared to the benchmark.
Performance of Pablo J Cagnoni
Pablo J Cagnoni Ownership Network
Pablo J Cagnoni Owned Company Details
What does Turmeric Acquisition Corp do?
Who are the key executives at Turmeric Acquisition Corp?
Pablo J Cagnoni is the director of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Executive Officer Luke Evnin , Chief Financial Officer Edward Hurwitz , and President Todd Foley .
Turmeric Acquisition Corp (TMPMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turmeric Acquisition Corp Insider Transactions
Pablo J Cagnoni Mailing Address
Above is the net worth, insider trading, and ownership report for Pablo J Cagnoni. You might contact Pablo J Cagnoni via mailing address: Onyx Pharmaceuticals, Inc., 249 E. Grand Ave., South San Francisco Ca 94080.